ArticleNeurogenetics2026
Novel deep intronic variant in CLCN1 causing autosomal recessive myotonia congenita.
Article in Neurogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myotonia congenita is a skeletal muscle channelopathy caused by pathogenic variants in CLCN1, encoding the ClC-1 chloride channel. We report two sisters with clinical features consistent with recessive myotonia congenita and compound heterozygous variants in CLCN1 identified through short-read genome sequencing: a paternally inherited pathogenic missense variant c.871G > A (p.Glu291Lys) and a novel maternally inherited deep intronic variant, c.697-620 T > G. RNA sequencing of a muscle biopsy revealed that the deep intronic variant activates a cryptic splice donor site, resulting in inclusion of an out-of-frame cryptic exon, multiple aberrant splice junctions and partial nonsense mediated decay. Allele-specific expression analysis showed a 70:30 skew favouring the paternal allele, supporting degradation of the maternally-derived transcript. These findings confirm the likely pathogenicity of c.697-620 T > G as a novel loss-of-function variant in CLCN1 and expand the spectrum of CLCN1-related autosomal recessive myotonia congenita.
Indexed as
Identifiers
42599553What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.